Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  bisantrene hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 44 for your search:
Start Over
Master Protocol to Compare MTX/5-FU vs CACP/5-FU vs Phase II Agent for Squamous Cell Cancer of the Head and Neck (Summary last modified 06/97)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8223/24/25, SWOG-8224, SWOG-8225
Phase II/III Chemotherapy with ADR vs DHAD vs ADC for Breast Cancer Not Previously Exposed to Intercalating Agents
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8203/04, SWOG-8204
Phase I-II Chemotherapy with ADC for Refractory Adult Acute Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: UMCC-8103
Phase I/II Mitoxantrone by Hepatic Arterial Infusion for Primary or Metastatic Hepatic Tumor Refractory to All Known Therapy
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UTHSC-82305005, CTEPIS-0146, NCI-W83-0089, W83-0089
Phase II Single-Agent Master Protocol for Advanced, Unresectable non-Small Cell Bronchogenic Carcinoma --- ADC (CL 216,942)
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-012-538, ICC-81L1
Master Protocol for Phase II Chemotherapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck --- ADC
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-070-646, WRAMC-8205
Phase II Chemotherapy with ADC on a Single-Dose Schedule for Advanced Renal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-8031
Phase II Chemotherapy with CL 216,942 in Women with Advanced Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UTHSC-BR-1
Master Protocol for Phase II Chemotherapy for Advanced or Metastatic non-Small Cell Lung Carcinoma --- ADC
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 16
Sponsor: NCI
Protocol IDs: CLB-8141
Phase II Chemotherapy with Anthracenedicarboxaldehyde for Advanced Gastric, Pancreatic, and Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 76
Sponsor:
Protocol IDs: EORTC-16822
Pilot Phase II Chemotherapy with Anthracenedicarboxaldehyde for Metastatic Breast Cancer That is Resistant to Conventional Therapy
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor: NCI
Protocol IDs: EST-PC-181
Phase II Chemotherapy with Single Agents Selected by Soft Agar Colony Sensitivity Studies for Advanced Renal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-805002, NCCTG-805002, NCI-W81-0587
Phase II Single-Agent Chemotherapy in Patients with Advanced Ovarian Carcinoma Using Agents Selected by Soft Agar Colony Sensitivity Studies
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-816101
Phase II Chemotherapy with Bisantrene for Refractory Childhood Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: NCI-82-C-117, NCI-POB-001
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Gastric Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8120
Phase II Chemotherapy with ADC in Patients with Hodgkin's and non-Hodgkin's Lymphomas Refractory to Standard Therapies (All Stages)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: UMCC-8110, NCI-W81-0573
Phase II Chemotherapy with ADC for Refractory Disseminated Small Cell Carcinoma of the Lung
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 to 69
Sponsor:
Protocol IDs: NYU-8101, NCI-V83-0061
Phase II Chemotherapy with Bisantrene for Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-012-696, ICC-81M2
Phase II Chemotherapy with Bisantrene for Advanced, Hormone-Resistant Stage D Prostatic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-012-886, ICC-81U3
Phase II Chemotherapy with Bisantrene by 72-Hour Continuous Infusion for Refractory Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-833201, NCI-T83-0873W, T83-0873
Phase II Chemotherapy with Bisantrene for Refractory Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8108
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Hodgkin's Disease and non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8116
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Ovarian Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8117
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8118
Start Over